marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q2
added 08-07-2023
Chinook Therapeutics Financial Statements 2011-2024 | KDNY
Annual Financial Statements Chinook Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.39 B | 744 M | 209 M | - | - | - | - | - | - | - | - | - |
Shares |
64.4 M | 45.6 M | 13.2 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
21.6 | 16.3 | 15.9 | 5.9 | 13.2 | 37.5 | 57 | 141 | - | - | - | - |
Net Income |
-188 M | -103 M | -81.6 M | -82.4 M | - | - | - | - | - | - | - | - |
Revenue |
6.13 M | 51.6 M | 827 K | 17.3 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 17.3 M | - | - | - | - | - | - | - | - |
Operating Income |
-185 M | -99 M | -56.2 M | -20 M | -101 M | -106 M | -71.9 M | -13.6 M | -19.1 M | -14.5 M | - | - |
Interest Expense |
- | - | - | 299 K | -64 K | -218 K | -40 K | -161 K | 2.38 M | 1.37 M | - | - |
EBITDA |
-182 M | -95.9 M | -55.1 M | -89.9 M | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 107 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
36.3 M | 31.9 M | 19.1 M | 34.8 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Chinook Therapeutics
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
71.6 M | 70.7 M | 65.5 M | 67.8 M | 62 M | 58.3 M | 54.8 M | 44.7 M | 43.9 M | 42.3 M | 42.3 M | 4.46 M | 4.47 M | 4.46 M | 4.5 M | 16 M | 80 M | 79.7 M | 79.6 M | 79.1 M | 78.8 M | 77.9 M | 77.7 M | 75.2 M | 71.1 M | 68.2 M | 67.9 M | 65.1 M | 64.4 M | 63.8 M | 63.6 M | 62.3 M | 52.7 M | 416 K | 362 K | 329 K | 295 K | 295 K | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-66.9 M | -60.2 M | - | -56 M | -37.6 M | -31.7 M | - | -30.7 M | -42.6 M | -37.2 M | - | -18.8 M | -7.74 M | -5.15 M | -19.4 M | -21 M | -18.6 M | -23.4 M | -26.3 M | -23.1 M | -24.4 M | -21.5 M | -26.1 M | -24.5 M | -19.4 M | -21.8 M | -29.6 M | -35.1 M | 2.3 M | -28.8 M | 3.1 M | 567 K | -26.3 M | -16.6 M | -920 K | -4.68 M | -3.63 M | -7.78 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
1.01 M | 1.83 M | - | 2.5 M | 418 K | 2.7 M | - | 4 K | 34 K | 351 K | - | 3.79 M | 5.57 M | 14 M | 3.63 M | 4.8 M | 4.89 M | 3.94 M | 2.76 M | 3.06 M | 2.64 M | 6.63 M | 3.76 M | 3.79 M | 5.92 M | 3.77 M | 3.88 M | 3.79 M | 39 M | 4.03 M | 34.4 M | 19.1 M | 9.88 M | 9.57 M | 9.89 M | 2.49 M | 985 K | 25 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-72.6 M | -61.4 M | - | -57.7 M | -36.7 M | -30.8 M | - | -31 M | -43.3 M | -37.1 M | - | -10.5 M | -7.75 M | -4.09 M | - | -24.5 M | -20.1 M | -24.9 M | - | -24.9 M | -25.8 M | -22.7 M | - | -29.3 M | -23.9 M | -25.2 M | - | -23.9 M | 3.26 M | -26 M | - | 425 K | -9.53 M | -7.28 M | - | -5.35 M | -6.55 M | -6.09 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 1.69 M | 767 K | -95 K | - | -69 K | -39 K | -67 K | - | 20 K | -4 K | 119 K | - | -32 K | -3 K | -19 K | - | 21 K | -20 K | -16 K | - | -129 K | -64 K | -4 K | - | -1 K | -9 K | -22 K | - | 3 K | 7 K | 8 K | - | 2.38 M | 996 K | 1.35 M | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-71.1 M | -60.5 M | - | -56.9 M | -35.9 M | -29.9 M | - | -30.2 M | -42.5 M | -36.4 M | - | -9.67 M | -6.95 M | -3.1 M | - | -23.4 M | -19 M | -23.8 M | - | -23.8 M | -23.6 M | -21.6 M | - | -26.7 M | -23.1 M | -24.4 M | - | -23.5 M | 3.64 M | -25.7 M | - | 587 K | -9.41 M | -7.19 M | - | -5.28 M | -6.5 M | -6.04 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | 37.5 M | - | 18.7 M | 22.6 M | 4.09 M | - | 29.3 M | 25 M | 28.9 M | - | 28 M | 28.4 M | 29.3 M | - | 33.1 M | 29.8 M | 29 M | - | 27.7 M | 35.7 M | 30.1 M | - | 18.7 M | 19.4 M | 16.9 M | - | 7.84 M | 7.54 M | 6.11 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
13.1 M | 11.4 M | - | 10 M | 8.64 M | 7.87 M | - | 6.85 M | 7.77 M | 9.54 M | - | 2.9 M | 3.88 M | 1.27 M | - | 8.6 M | 7.83 M | 8.22 M | - | 9.15 M | 8.83 M | 9.04 M | - | 8.46 M | 8.24 M | 8.28 M | - | 8.56 M | 8.7 M | 9 M | - | 6.91 M | 5.88 M | 6.21 M | - | 1.98 M | 2.13 M | 1.38 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency